Evolving strategies for preserving the pulmonary valve during early repair of tetralogy of Fallot: Mid-term results  by Vida, Vladimiro L. et al.
Vida et al Congenital Heart DiseaseEvolving strategies for preserving the pulmonary valve during early
repair of tetralogy of Fallot: Mid-term resultsVladimiro L. Vida, MD, PhD,a Alvise Guariento, MD,a Biagio Castaldi, MD,b Matteo Sambugaro, MPH,c
Massimo A. Padalino, MD, PhD,a Ornella Milanesi, MD,b and Giovanni Stellin, MDaFrom th
Cong
of Pe
tics C
sity o
Disclos
Read at
gery,
Receive
publi
Address
Vascu
Via G
0022-52
Copyrig
http://dx
C
H
DBackground: The aim of the study was to evaluate our results with pulmonary valve (PV) preservation in
selected patients with tetralogy of Fallot (TOF).
Methods: From January 2007, 69 patients who underwent early transatrial TOF repair were enrolled in the
study. The patients were divided into 2 groups: PV preservation by PV annulus balloon dilation (group 1) and
PV cusp reconstruction after annular incision (group 2).
Results: Thirty-four patients underwent a successful PVannular preservation (49%). Median age at surgery was
113 days (range, 36-521 days) (group-1 vs group-2, P ¼ not significant). Median preoperative PV Z score was
3.15 (range,0.95 to5.62) (group-1 vs group-2, P¼ .03). Median intensive care unit and hospital stays were
3 and 10 days, respectively (group 1 vs group 2, P ¼ not significant). Median follow-up time was 580 days
(range, 189-1940 days) (group 1 vs group 2, P¼ .08). Two patients were reoperated for residual right ventricular
outflow tract (RVOT) obstruction (1 in group 1 and 1 in group 2). The remaining patients are alive and well.
Median peak RVOT gradient was 25 mm Hg (range, 8-60 mm Hg) (group 1 vs group 2, P ¼ not significant).
The degree of PV regurgitation in group 1 was none/mild in 24 patients (80%) and moderate in 6 (20%) and
was none/mild in 8 patients (25%), moderate in 11 (34.4%), and severe in 13 (28.6%) in group 2
(P ¼ .001). Median right ventricular fractional area change was 55% (range, 42%-70%) in group 1 and
50% (range, 40%-63%) in group 2 (P ¼ .003).
Conclusions: The integrity and function of the PV can be preserved in selected patients during early repair of
TOF by concomitant balloon dilation, leading to a better mid-term right ventricular function. (J Thorac Cardi-
ovasc Surg 2014;147:687-96)Tetralogy of Fallot (TOF) repair is now routine practice and
can be achieved with low surgical risk in many pediatric
cardiac centers. Correction via a right ventriculotomy
with transannular right ventricular outflow tract (RVOT)
patch reconstruction is still the most frequent approach.1
More recently, a transatrial approach has become
the preferred procedure and it yields excellent early
and mid-term results.2-10 The objective of a transatrial
repair is to avoid (or minimize) structural damage to
the subpulmonary pump, which has proved to be the
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The Journal of Thoracic and CaHowever, use of a transannular patch, although necessary
in some cases, often results in pulmonary insufficiency with
chronic right ventricular volume overload, leading inevi-
tably to progressive right ventricular dilation and dysfunc-
tion that is associated with impaired functional
capacity.1-5,8,9 Augmentation plasty of the pulmonary
valve (PV) leaflets can avoid PV regurgitation early
postoperatively, improving the short-term clinical
outcome.3 Nonetheless, leaflet function often deteriorates
over time resulting in progressive PV regurgitation.11-19
The interest in preserving PV function has stimulated
surgeons to devise valve-sparing techniques for TOF
repair.20-27 In recent years, we have combined, in selected
cases, our routine early transatrial transpulmonary repair
with intraoperative balloon dilation of the hypoplastic
pulmonary annulus.22
The aim of this study is to evaluate the early andmid-term
results of this approach to early repair of TOF, focusing on
PV and right ventricular function in comparison with our
standard transatrial/transpulmonary repair technique.METHODS
Review of medical records and computerized hospital data was
approved by the Clinical Investigation Committee from the University
Hospital of Padua, and the procedures followed were in accordance with
the institutional guidelines for retrospective record review and protectionrdiovascular Surgery c Volume 147, Number 2 687
Abbreviations and Acronyms
PV ¼ pulmonary valve
RCA ¼ right coronary artery
RV ¼ right ventricular
RVFAC ¼ right ventricle fraction of area change
RVOT ¼ right ventricular outflow tract
TOF ¼ tetralogy of Fallot
VSD ¼ ventricular septal defect
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Dof patient confidentiality. Individual consent was not obtained by patients
enrolled in this study. Patients are not identified, and the chairperson of
the Ethics Committee of our institution consented to publication of their
data.
From June 2007, all patients who underwent repair of TOF at our insti-
tution were enrolled in the study. Patients with mild forms of TOF who did
not require surgical manipulation of the PV, TOF with severe pulmonary
valve stenosis and diminutive pulmonary artery branches with aortopulmo-
nary collaterals who were treated by right ventricle–pulmonary artery
conduit interposition, TOF with absent PV, double-outlet right ventricle,
and adult patients undergoing repair of TOF were excluded.
Our standard institutional policy for TOF repair in early infancy since
June 1991 (usually in patients 3 months of age) includes (1) the
transatrial/transpulmonary approach to the subpulmonary outflow tract,
(2) incision of the PV annulus with minimal right ventriculotomy
(3-5 mm) when necessary, and (3) transatrial closure of the ventricular
septal defect using an autologous pericardial patch.24
PV function is reestablished by the use of a pulmonary homograft
monocusp patch, tailored at the annular level, to match the posterior natural
leaflets (up to 2007) or by adding either a polytetrafluoroethylene (0.1 mm
diameter) or CorMatrix ECM Technology (CorMatrix Cardiovascular Inc,
Sunnyvale, Calif) leaflet under the RVOT enlargement patch.
Since 2007, we have attempted to preserve the PVannulus anatomy and
function by intraoperative PV balloon dilation in selected patients. After a
longitudinal pulmonary arteriotomy, the PVorificewas sized on the beating
heart using a Hegar dilator (Table 1) to assess the effective diameter of the
PV orifice. Valvular commissurotomy was routinely performed up to the
sinutubular junction and the valve was sized again with a Hegar dilator
to check the real annular diameter and to calculate the effective PV
Z score.28 After the subpulmonary muscular obstruction was relieved
through the tricuspid valve up to the hinges of the PV leaflets, and the
ventricular septal defect (VSD) was closed, a valvuloplasty balloon was
then introduced through the tricuspid valve across the PV orifice and
inflated under direct vision until the inner pressure reached 10 atmospheres.
We chose short (2 cm), high-pressure (>10 atmospheres), noncompliant
balloons,22 sized according to the calculated size of the PVorifice relative
to the body surface area of the patient. At the end of the procedure, the
diameter of the PV was sized again with an appropriate Hegar dilator to
check the results of the dilation, and the valve was carefully examined
to exclude any possible iatrogenic lesion (Figures 1 and 2).
This new technique was initially used in selected patients with milder
forms of TOF (Z score  3). The criteria for using this approach have
recently evolved to include patients with a Z score of 4 or lower. When
dealing with a hypoplastic PVannulus (Z score between 3 and 4) after
an initial PV commissurotomy followed by PV balloon dilation (up to the
expected PV dimension for the body surface area), the PV leaflets, which
have often been separated at the commissure level, are reconstructed by
carefully delaminating the PV hinge point with a fine scalpel down to
the right ventricular (RV) epicardium, thus extending the leaflet’s coapta-
tion area (Figures 1 and 2). Subsequently, the extended leaflets are
resuspended at the level of the new PV commissure or further extended688 The Journal of Thoracic and Cardiovascular Surgby means of a small prosthetic (biological) patch and then resuspended.
An appropriate Hegar dilator for the PV size (PV Z score ¼ 0) is passed
through the new PV annulus.
Particular care is taken to remove any possible RVOT obstruction up to
the subannular level by combining transatrial, transtricuspid, muscle band
resection and a further transpulmonary residual muscle band excision
through the PV annulus, before and after balloon dilation.
Clinical Data and Outcomes
Transesophageal or epicardial echocardiography was used to monitor
the immediate surgical results. Patients were evaluated by echocardiogra-
phy (iE33 xMATRIX Echocardiography System, Philips Medical System,
Andover, Mass) at hospital discharge and during outpatient follow-up.
Patients who were followed for less than 6 months after surgery were
excluded from the analysis (n¼ 7 patients, 4 of whom underwent PV pres-
ervation and 3 a standard TOF repair). Two patients who required a reop-
eration for residual RVOT obstruction after the initial repair were also
excluded.
RVOT obstruction was quantified using Doppler echocardiography and
classified as mild (<20 mm Hg), moderate (between 20 and 40 mm Hg), or
severe (>40 mm Hg). Pulmonary regurgitation was quantified as (1) none-
mild, (2) moderate, or (3) severe.29,30 Right ventricular function was
measured using the fractional area change (RVFAC).31,32 The two-
dimensional echo images were retrospectively reviewed in the echocardi-
ography laboratory by a single staff pediatric cardiologist, whowas blinded
to the surgical procedure.
The primary outcome of this study was to assess the effectiveness of the
PV preservation technique by focusing on mid-term PV and RV function.
These results were compared with those of our standard transatrial repair
with transannular patch (TAR-TAP) performed during the same time inter-
val (including patients who had a failed PV preservation and whowere con-
verted to a standard TOF repair) (group 2).
Categorical variables are shown as absolute frequencies and percent-
ages. Quantitative variables were summarized as the median and range.
When quantitative variables were not normally distributed (assessed by
the Shapiro-Wilk normality test), comparison between groups was done us-
ing the Kruskal-Wallis test. Categorical variables were compared using the
c2 test or the Fisher exact test. Linear regression analysis was used to test
the relationship between residual RVOTobstruction or PV regurgitation at
follow-up and ventricular function. All reported P values are 2-sided. Sta-
tistical analysis was performed using Stata software (release 10.0 for Win-
dows; Stata Corporation, College Station, Tex).RESULTS
Sixty-nine patients were included in our study. Median
age at surgery was 113 days (range, 36-521 days). In 39 pa-
tients, we attempted to preserve PV integrity. The remaining
30 patients, most of them at the beginning of our experi-
ence, underwent a standard transatrial/transpulmonary
repair. In accordance with our policy of early repair, none
of the patients had previously undergone a palliative proce-
dure except for 1 patient from another institution in whom a
stent had been placed in the patent ductus arteriosus at 1
month of age for severe arterial oxygen desaturation.
The median preoperative transcutaneous oxygen satura-
tion was 93% (range, 80%-100%). Three patients
(4.3%) had repeated cyanotic spells. The preoperative
transcutaneous oxygen saturation was significantly higher
(P ¼ .03) in patients who had preservation of the PV
(Table 1).ery c February 2014
TABLE 1. Preoperative, intraoperative, and postoperative data (n ¼ 69 patients)
Surgical groups
P valuePV dilatation group (n ¼ 34) Standard TA/TP repair group (n ¼ 35)
Median age at surgery, d (range) 115 (36-521) 113 (65-454) .41
Men, n (%) 19 (55.9) 17 (48.6) .7
Median weight at surgery, kg (range) 5.7 (4.6-10) 6.0 (3.2-10.1) .92
Median body surface area, m2 (range) 0.3 (0.25-0.46) 0.3 (0.22-0.45) .46
Median two-dimensional echo PV annulus, mm (range) 6.8 (5.5-8.8) 6 (4-9.5) .02
Median PV Z score on 2 dimensions, n (%) 2.95 (0.95 to 4.06) 3.35 (1.54 to 5.62) .03
Median preoperative transcutaneous O2 saturation,% (range) 94 (80-100) 90 (80-100) .03
Median preoperative RVOT gradient, mm Hg (range) 67 (40-87) 70 (55-93) .12
Coronary anomalies, n (%) 1 (2.9) 4 (11.4) .36
Median effective PVorifice,* mm (range) 5 (4-8) 5 (3-8) .0015
Median postcommissural annulus, mm (range) 7 (6-9) na
Median CPB time, min (range) 125 (93-200) 158 (104-237) .0001
Median crossclamp time, min (range) 76 (45-118) 75 (48-114) .93
RVP/SBP after CPB discontinuation, n (%)
1/3 8 (23.5) 10 (28.6)
1/2 19 (55.9) 21 (60) .56
3/4 7 (20.6) 4 (11.4)
Median ICU stay, d (range) 3 (1-8) 3 (1-12) .46
ICU complications, n (%) 11 (32.4) 8 (22.9) .54
Postoperative junctional tachycardia, n (%) 6 (17.6) 1 (2.9) .04
Postoperative low output syndrome, n (%) 3 (8.8) 3 (8.6) .99
Median hospitalization, d (range) 10 (7-43) 10.5 (7-31) .7
PV, Pulmonary valve; TA/TP, transatrial/transpulmonary; RVOT, right ventricle outflow tract; na, not applicable; CPB, cardiopulmonary bypass; RVP, right ventricular pressure;
SBP, systemic blood pressure; ICU, intensive care unit. *Sized by Hegar dilators before any maneuver of the pulmonary valve.
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the PV diameter was 3.15 (range, 0.95 to 5.62); the
median peak gradient across the pulmonary outflow tract
was 69 mm Hg (range, 40-93 mm Hg).
At the time of surgery, the PV was found to be bicuspid in
59 patients (85.5%), tricuspid in 6 (8.7%), and unicuspid in
4 (5.8%). Five patients (7.2%) had coronary artery anoma-
lies including (1) right coronary artery (RCA) from the left
anterior descending crossing the RVOT (n ¼ 2), (2) major
conal branch coronary artery from the RCA crossing the
RVOT (n ¼ 2), and (3) anomalous origin of the RCA from
the main pulmonary artery trunk crossing the RVOT (n¼ 1).
In 34 of the 39 patients considered to be suitable candi-
dates (87%), it was possible to preserve the PV annulus.
In the remaining 5 patients, we converted our initial attempt
at PV dilatation into a standard transatrial/transpulmonary
repair including reconstruction of the pulmonary leaflets
and patch augmentation of the pulmonary trunk. The PV-
sparing procedure failed because of tearing of the hinges
of the valve leaflets caused by use of an oversized balloon
catheter early in our experience in 3 patients and a low
PV Z score (<4) in 2 patients. Preoperative variables ac-
cording to the surgical group and the type of repair and pre-
operative PV morphology are listed in Table 1.
As previously described,22 an in-series balloon strategy
was performed in 15/34 patients (44.1%). This techniqueThe Journal of Thoracic and Caconsisted of using balloon catheters of increasing diameter
to allow progressive stretching and dilation of the PV
annulus to eventually reach the expected value of PV
annulus for the body surface area of the patient and to pre-
vent accidental tears of the PV annulus. Patients treated by
an in-series balloon dilation had a lower preoperative
median PV Z score (3.56, range, 2-28 to 4.06 vs
2.39, range, 0-95 to 3.74) (P ¼ .0024).
Eighteen patients required an additional surgical
maneuver on the dilated PV (52.9%), which included
(1) resuspension of the leaflets (n ¼ 4); (2) PV leaflets
delamination and resuspension (n ¼ 11); or (3) leaflets
delamination, leaflet patch augmentation, and resuspension
(n ¼ 3).
Median cardiopulmonary bypass (CPB) time was 134
minutes (range, 93-237 minutes) and was higher in patients
who underwent classic TOF repair (P ¼ .0001, Table 1).
Median crossclamp time was 76 minutes (range, 45-118
minutes) and did not differ significantly between groups.
At the end of the CPB procedure, the RV pressure was
measured by direct puncture and was less than one-third
of the systemic pressure in 18 patients (26.1%), less than
half of the systemic pressure in 40 patients (58%), and
less than three-quarters of the systemic pressure in 11 pa-
tients (15.9%); it did not differ significantly between
groups (Table 1).rdiovascular Surgery c Volume 147, Number 2 689
FIGURE 1. Cartoon showing the balloon dilation technique: A, Protective commissurotomy; B, B0, balloon dilation of the pulmonary valve annulus; C, C0,
status after balloon dilation showing the gap of pulmonary valve tissue after the dilation procedure; D, D0, leaflet delamination procedure (to increase the
pulmonary valve coaptation surface); E, resuspension plasty (to avoid leaflet prolapse).
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DMedian time in intensive care was 3 days (range, 1-12
days). The incidence of temporary postoperative junctional
tachycardia was significantly higher in patients who under-
went PV preservation (P ¼ .04, Table 1).
The median RVOT gradient did not differ significantly
between the 2 groups at the discharge echocardiogram
(Table 2). However, patients who had undergone the PV-
sparing procedure had significantly less pulmonary regurgi-
tation (P ¼ .0001, Table 2).Follow-up
Median follow-up time was 580 days (range, 189-1940
days), and was longer for patients who underwent standard
repair (P¼ .08, Table 3). Two patients required reoperation
for residual RVOTobstruction greater than 50 mm Hg, 1 af-
ter PV preservation early in our experience and 1 after stan-
dard TOF repair. The remaining 67 patients are
asymptomatic, in sinus rhythm, and doing well without
medication.
At the most recent two-dimensional echocardiogram, the
median RVOT gradient was 22 mm Hg (range, 7-45 mm)
and did not differ significantly between the 2 groups
(Table 3). The severity of PV regurgitation was significantly
less in the PV preservation group (P ¼ .001, Table 3).690 The Journal of Thoracic and Cardiovascular SurgIn the PV preservation group, there was a significant cor-
relation between preoperative PV Z score and the severity
of PV regurgitation at follow-up (P ¼ .003). Five of 6 pa-
tients with moderate PV regurgitation had a preoperative
Z score less than 3.5.
There was also a significant correlation (P< .001) be-
tween the grade of PV regurgitation and RV function at
follow-up (Figure 3). The RVFAC was significantly higher
in patients who underwent PV preservation (P ¼ .02)
(Table 3).
The Z score of the PVorifice (calculated only in patients
who underwent PV preservation) at the last follow-up two-
dimensional echo evaluation seemed to be adequate for the
patient’s body surface area, with a median valued of 0.1
(range, 0.3 to þ0.7).DISCUSSION
Continuous improvements in surgical techniques and
postoperative management have made the repair of TOF
feasible in early infancy with a low risk.5,17-20 Despite
awareness of the late consequences of PV regurgitation,
ventriculotomy with transannular patch placement
remains the most prevalent technique for repair of
patients with TOF.5ery c February 2014
FIGURE 2. Intraoperative images of a 3.5-month-old boy with tetralogy of Fallot showing the pulmonary valve preservation technique. A, The effective
PVorifice; B, the protective commissurotomy (white arrow); C, balloon dilation of the PV (*, balloon catheter); D, PVafter balloon dilation; E, PV leaflet
delamination (black arrow); F, leaflet patch augmentation (black and white arrows) and resuspension. PV, Pulmonary valve; Ao, ascending aorta; LPA, left
pulmonary artery; MPA, main pulmonary artery.
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repair, other centers17-26 have developed techniques with
the aim of limiting PV regurgitation, thus preserving PV
function and eliminating or minimizing a large right
ventriculotomy, with the aim of avoiding late RV dilation
and dysfunction, and the occurrence of ventricular
arrhythmias.12,13
Since the early 1990s,3-24 we have developed different
surgical approaches at our institution, with the aim of
achieving the best surgical result in the long-term but main-
taining a low operative risk.TABLE 2. Two-dimensional echocardiographic data at discharge
PV dilatation group (n ¼
Degree of TV regurgitation, n (%)
Grade 1 (none-mild) 30 (91.2)
Grade 2 (moderate) 3 (8.8)
Grade 3 (severe) —
Median RVOT gradient, mm Hg (range) 29 (18-50)
RVOT gradient grade, n (%)
Grade 1 (<20 mm Hg) 1 (2.9)
Grade 2 (20-40 mm Hg) 30 (88.2)
Grade 3 (>40 mm Hg) 3 (8.8)
Degree of PV regurgitation, n (%)
Grade 1 (none-mild) 30 (88.2)
Grade 2 (moderate) 4 (11.8)
Grade 3 (severe) —
PV, Pulmonary valve; TA/TP, transatrial/transpulmonary; TV, tricuspid valve; RVOT, right
The Journal of Thoracic and CaIn the early 1990s, we first adopted an elective primary
surgical repair in early infancy, combined with a transatrial
transpulmonary approach that has eliminated the delete-
rious effects of a 2-stage repair.3 Subsequently, in the
mid-1990s, we electively included the use of a monocusp
patch (autologous pericardium, a polytetrafluoroethylene
patch of pulmonary homograft) when a transannular patch
is required, to achieve valvular competence, thus producing
better short-term and mid-term surgical outcomes.3,6-11
During the past few years, the long-term results of stan-
dard TOF repair reported with increasing frequency casesSurgical group
P value34) Standard TA/TP repair group (n ¼ 35)
33 (94.3)
2 (5.7) .48
—
25 (12-50) .18
7 (20)
26 (77.1) .07
1 (2.9)
14 (40)
9 (25.7) .0001
12 (34.3)
ventricle outflow tract.
rdiovascular Surgery c Volume 147, Number 2 691
TABLE 3. Two-dimensional echocardiographic data at follow-up
Surgical group
P valuePV dilatation group (n ¼ 30) Standard TA/TP repair group (n ¼ 32)
Median follow-up time, d (range) 432.5 (189-1940) 711.5 (189-1492) .08
Degree of TV regurgitation, n (%)
Grade 1 (none-mild) 30 (100) 32 (100)
Grade 2 (moderate) — — na
Grade 3 (severe) — —
Median RVOT gradient, mm Hg (range) 23.5 (8-40) 22 (7-45) .85
RVOT gradient grade, n (%)
Grade 1 (<20 mm Hg) 18 (60) 18 (56.3)
Grade 2 (20-40 mm Hg) 12 (40) 12 (37.5) .37
Grade 3 (>40 mm Hg) — 2 (6.3)
PV Z score, n (range) 0.1 (0.3 to þ0.7) — —
Degree of PV regurgitation, n (%)
Grade 1 (none-mild) 24 (80) 8 (25)
Grade 2 (moderate) 6 (20) 11 (34.4) .001
Grade 3 (severe) — 13 (40.6)
Median RVFAC, n (%) 55 (42-70) 50 (40-63) .003
PV, Pulmonary valve; TA/TP, transatrial/transpulmonary; TV, tricuspid valve; na, not applicable; RVOT, right ventricle outflow tract; RVFAC, right ventricle fraction of area
change.
FIGURE 3. Linear regression analysis showing the correlation (P<.001)
between the grade of pulmonary valve regurgitation (PVR) and right ven-
tricular (RV) function at follow-up.
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Dof RV failure, which was produced mainly by free PV regur-
gitation; at the same time, we were impressed by the results
that our colleagues were achieving on PV dilatation in iso-
lated PV stenosis. Therefore, we embarked on a new surgi-
cal approach that combines all the previous surgical
techniques and includes the preservation of the native PV.
We were confident about the recently acquired tech-
niques on aortic valve preservation, which could be trans-
ferred to preserving PVs in patients with TOF, consisting
of leaflet delamination, shaving, leaflet augmentation, tear
repair, and new commissure resuspension. It is obvious
that such techniques have shown better results when applied
in a low pressure system compared with the systemic
system.
Our study has demonstrated that the PV annulus and
function can be preserved in selected patients undergoing
early surgical repair of TOF, by combining a transatrial/
transpulmonary subpulmonary muscular resection, VSD
closure, without transgressing on the ventriculo-arterial
junction.
During our early experience, we limited such a technique
to patients with a PV Z score of 3 or higher only. More
recently, as our experience has expanded, we have extended
the use of this technique to patients with more severe PV
annulus hypoplasia (Z score4).We believe that our suc-
cess is linked to the in-series balloon dilation strategy,
which allows more progressive stretching of the PVannulus
fibers (thus avoiding unexpected ruptures). Furthermore,
the new concept of PV leaflet delamination allowed us to in-
crease the PV leaflets coaptation area to fill the gap created
at the commissure level after balloon dilation. In addition,
an aggressive PV plasty was performed, especially in pa-
tients with a small PV annulus, to achieve a good valve692 The Journal of Thoracic and Cardiovascular Surgthat was competent at the end of the surgical repair. It is
obvious that complete resection of obstructing muscle tis-
sue, up to the PV annulus, needs to be performed before
and after PV balloon dilation.
Soon after the crossclamp, the PV was initially carefully
inspected and sized. A protective careful incision at each
commissure was carried out in all patients before balloon
dilation, with the aim of allowing the PV annulus to dilate
at the commissure level, thus avoiding any damage to theery c February 2014
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DPV leaflets. Care must also be taken when choosing the
appropriate size of the dilating balloon. We have used
high-pressure noncompliant balloons. The radial force of
the dilation is distributed around the circumference of the
PV, thus obtaining homogeneous stretching of the elastic fi-
bers of the PV annulus; these are important principles that
can never be achieved by forcing a Hegar dilator through
the PV annulus (longitudinal force), as others have
reported.20
Our balloons were systematically inserted through the
RVOT into the PVand held in that position to avoid balloon
dislodgement during dilation. In contrast to our interven-
tional cardiologist colleagues, who often oversize the
balloon when dilating PVs, we found that it is important
not to oversize the balloon. Excessive dilation in an open
field can overstretch the valve, inevitably leading to irrepa-
rable PV damage.
According to our mid-term results, preservation of the PV
was possible in almost half of the cases of repaired TOF
treated in our institution since 2007. Our positive results al-
lowed us to achieve significantly better PV competence and
RV function in the mid-term. These results were optimal in
patients with a Z score of 3 or higher. Recently, however,
we extended the application of this technique to patients
with a PV Z score down to 4. The smaller the annulus,
the more frequently lesions on the PV were observed.
Nevertheless, we could repair them promptly, eventually
obtaining a competent PV.
A 2-stage repair has a hypothetical advantage of a higher
PV preservation rate.33,34 Surgical palliation by means of a
modified Blalock-Taussig shunt continues to be indicated in
many centers for patients with a low body weight or in pa-
tients with diminutive pulmonary arteries. It allows the
growth of the pulmonary arteries and of the PV, thus
possibly allowing a higher rate of PV preservation, however
it is associated with significant morbidity and mortality,33
both early and in the long term. The use of RVOT stenting
has also been advocated as an alternative approach to allow
the growth of the pulmonary arteries in symptomatic neo-
nates with TOF, however, it may jeopardize PV integrity,
possibly precluding its preservation. Percutaneous stabili-
zation of the arterial duct, with highly flexible coronary
stents, has been introduced and developed since 2003.34,35
This technique has been shown to be safe and effective in
promoting significant and balanced growth of the
pulmonary arteries. This technique may be considered in
the future for more severe forms of TOF as a bridge to
complete repair, especially in symptomatic patients, with
the aim of combining the development of the pulmonary
vascular tree and the PV apparatus, possibly leading to a
higher PV preservation outcome.35 In our experience, truly
hypoplastic pulmonary arteries have been rarely encoun-
tered in classic TOF, in the absence of a systemic-
pulmonary collateral circulation. When present, they areThe Journal of Thoracic and Causually confined to those cases with intrinsic pulmonary
artery disease.
This study has some limitations. It is a retrospective
study. The population with treated TOF is still small and
the follow-up time is still short, therefore we cannot reach
definitive conclusions about the validity of this new surgical
technique. Nonetheless, our early and mid-term results with
this new technique are encouraging and superior to those
obtained after standard treatment of TOF at our institution.
We are still in the learning phase of a new technique. In
every case that we deal with, we include new techniques,
which are important not only for preserving the integrity
of the PVannulus but also for its reconstruction, so that suf-
ficient PV dilation is achieved.
In conclusion, PV function can be preserved during early
TOF repair and this can help to avoid long-standing RV
dysfunction, and possibly future interventions for treating
PV regurgitation, thus potentially changing the natural his-
tory of patients with repaired TOF.We have recently further
expanded the applicability of the technique to patients with
an increasingly smaller PV annulus; in-series balloon dila-
tion and the delamination technique are key to achieving
acceptable PV competence after the operation and at
follow-up. It is our policy now to attempt PV dilation in
all patients with classic TOF patients with a Z score of
4 or higher. When total valve preservation cannot be
achieved, the ventricular muscle incision is usually minimal
and acceptable PV competence can always be achieved.References
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Dr Frank Hanley (Stanford, Calif). Dr Vida and his colleagues
have addressed an important issue, that is, maximizing mainte-
nance of pulmonary valve annular integrity during tetralogy of
Fallot repair. There is a long history focusing on maintenance of
pulmonary valve annular integrity in tetralogy of Fallot dating
back to the early work of John Kirklin, who primarily focused
on Z scores alone.
Over the years many technical maneuvers have been suggested
to improve the percentage of patients in whom the annulus is
preserved. In recent years, the introduction of intraoperative
balloon dilation of the annulus has been introduced as one of these
options, somewhat parallel to Hegar dilation or other forms of
dilation of the valve. Several publications since 2007 have
retrospectively assessed the potential benefit of this technique.
This study by Dr Vida and his colleagues is the first to
incorporate at least some degree of prospective design. The
authors prospectively assigned cohorts of patients either to receive
or not to receive an intraoperative balloon procedure versus the
standard treatment. And they used a predefined anatomic
characteristic, the size of the pulmonary annulus preoperatively,
to determine which group the patients would belong.
The results are encouraging that this may be a useful technique
and the study is an important contribution. There are, however,
uncertainties and significant limitations with respect to drawing
definitive conclusions based on the results. I have a few questions
that address those potential limitations.
The first relates to study design. It seems unfortunate that you
did not match the patients based on their pulmonary valve annular
size. So as it turns out, you have picked a favorable anatomic group
who get the preservation and a more unfavorable anatomic group
that received the standard technique, so you can see where a
potential bias would be present in the long-term results. Why
did you not decide to do a matched control of the pulmonary valve
annular size and just randomize matched patients into those
2 groups? It would have been easy to do.
Dr Vida. We started to apply this technique a few years ago.
At the beginning, we decided to start with milder forms of
tetralogy of Fallot with less severe pulmonary valve Z scores. As
we have gained more experience with this new technique, we
have been treating even more severe forms of tetralogy of Fallot.
Our initial limit for choosing the balloon dilation technique was
a pulmonary valve Z score equal to or more than 3, and this, at
the beginning, was surgeon dependent. In the last couple of years,
with the advent of more aggressive additional pulmonary valve
plasty techniques, such as leaflet delamination, we decided to be
more aggressive, applying this technique in patients with a Z score
as low as 4.
Initially, we had a tendency to oversize our balloon catheters
during the pulmonary valve dilation phase, based on theery c February 2014
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colleagues usually go up to 120% to 150% of the initial pulmonary
valve diameter. However, we have learned that, to avoid
unexpected tears of the pulmonary valve leaflet or annulus during
the dilation, it is better to dilate the annulus up to the expected
normal value for the patient’s body surface area by using
high-pressure noncompliant balloons.
As you pointed out, 1 of the major limitations of this study is
that it is not a prospective randomized clinical trial. We analyzed
our patient population in a retrospective fashion, comparing
patients who underwent pulmonary valve preservation with
patients who underwent a standard transatrial/transpulmonary
repair technique.
Looking back at our results, we were able to preserve almost
half of the pulmonary valves in our patients with tetralogy of
Fallot. However, we can speculate, considering the latest
achievements with this technique, that we could have saved
more valves during the early stages of our experience, potentially
saving the pulmonary valve in up to the 75% of our patients.
Dr Hanley. So I mean clearly this was more learn-as-you-go
than prospectively designing. The read of the paper, in all fairness,
sounds a little bit more like it was prospectively set up that way.
But we have all been there, and learning as we go is a good
technique, I am not criticizing that at all.
Another question relates to the follow-up. There is a
discrepancy in the median follow-up periods for the 2 groups,
and it is large: 433 days for the balloon group and 712 for the other
group. And importantly, over the 433 days of follow-up for the
preservation group, the percentage of patients who developed
significant regurgitation almost doubled from 11.8% to 20%.
A skeptic I guess could argue that if the preservation group was
allowed to go out to 712 days, almost another 300 days, if there
was another point on the curve, there was probably going to be a
significant increase further, because it has already been
demonstrated there has been some, a further increase in the
amount of regurgitation, and would it be different than the control
group?
Dr Vida. Yes, the follow-up time is different between out study
groups. In fact, as we became more familiar with the pulmonary
valve preservation technique, we were able to preserve most
pulmonary valves during early repair of tetralogy of Fallot,
especially in the last few years; this contributed to the shorter
follow-up time in the preservation group.
Nonetheless, the shorter postoperative follow-up time, and
because we are still in a learning phase with this new technique,
our results are encouraging. In fact, most patients in the
preservation group, almost 90%, were discharged home with
none to trivial pulmonary valve regurgitation. Only a few of
them, all with severe forms of tetralogy of Fallot, had a moderate
degree of pulmonary valve regurgitation.
On the contrary, when we used an artificial cusp to achieve
pulmonary valve competence during transannular patch repair,
we have since the beginning had a higher frequency of more severe
forms of valve regurgitation, which progressed over time in most
patients.
Dr Hanley. Absolutely. You have clearly shown that short term
you come up with less regurgitation. I guess the concern is way
further out.The Journal of Thoracic and CaOne last brief question. For what percentage of the patients in
the preservation group did you use artificial material on the patch?
Because I would say, and I will not respond after, but my concern
there is the more you use artificial material on a young infant,
pulmonary valve or any valve, the more likely you are going to
have failure later.
Dr Vida. We needed to use biological material in 4 patients
during pulmonary valve preservation. All these patients had
more severe forms of tetralogy of Fallot, with an initial Z score
less than 3.5. These patches were used to further extend the
pulmonary valve leaflet coaptation area after balloon dilation
and leaflet delamination, in order to achieve optimal valve
competence.
Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
You bring up a novel concept, this concept of the delamination
to extend the size of the pulmonary valve leaflets, and I think
that would warrant some more discussion in terms of what the
limits are to that technique and there may be a few tips that you
may have in that regard. Can you just give us the briefest of
comments on that.
Dr Vida. The pulmonary valve in patients with tetralogy of
Fallot is usually thick and dysplastic and in most cases bicuspid.
Following balloon dilation, a gap in the valvular tissue is usually
present at 1 commissure level. In order to fill this gap and to
make that valve competent, we extend the pulmonary leaflets by
delaminating them at the hinge point level down to the right
ventricular myocardium.
After delamination, a good coaptation between leaflets is
usually achieved, however leaflets are usually prolapsing and
need to be resuspended recreating a new commissure. If the
leaflet is too short after delamination, the risk is a decrease in
its motion after resuspension. To avoid the creation of a still,
immobile leaflet, we decided to extend 1 leaflet end by means
of a prosthetic patch. An initial concern deriving from the
delamination process was possible right ventricular muscle
blood infiltration. However, it did not happen in our patients,
possibly because the delaminated site is exposed to the pressure
of the pulmonary district, which is usually low in patients with
tetralogy of Fallot.
Dr Caldarone. It is very interesting.
Dr Emile Bacha (New York, NY). Nicework. As you know, I am
a proponent of the technique, but I have given it up for the severe
end of the spectrum of tetralogy of Fallot. I do not use it anymore
for very low Z scores or severely stenotic valves. I use it for
the moderate range of Z scores up to 2.5, 3. I do not really
like to use Z score either because it does not take into account
the morphology of the pulmonary valve, and only measures
the annular size with no accounting for the effective orifice and
the cusp morphology.
However, it seems to me what you are doing is using a balloon
as only 1 of the steps in your management of your severe tetralogy
of Fallot spectrum. You are using patches, you are putting stitches
in the valve. And so I would agree with Dr Hanley’s comment that
probably what you are going to see long term is more pulmonary
regurgitation developing because you have instrumented this valve
so much by necessity. And in my view, I would rather do a
controlled surgical intervention on a severely stenotic valve,
such as dividing it where I want to, as opposed to having a balloonrdiovascular Surgery c Volume 147, Number 2 695
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reconstruct this valve.
Dr Vida.Well, I agree with you. This treatment is appealing for
milder forms of tetralogy of Fallot with a pulmonary valve Z score
of 3 or higher. With the advent of a more aggressive approach,
we were able to treat more severe forms, and, so far, have achieved
good mid-term results. These results are significantly superior to
the results from our standard transatrial/transpulmonary approach.
However, a longer follow-up is certainly mandatory to prove the
efficacy of this technique.
Dr Bacha. I do not disagree with plasty for the valve and
working on the valve trying to preserve it. But I am saying that,696 The Journal of Thoracic and Cardiovascular Surgat the severe end of the spectrum, you probably have more control
over what you do with this valve if you divide it where you want it,
as opposed to introducing a balloon. The valve may tear in a place
that you do not want it to tear.
Dr Vida. Because of its high success rate, our current policy is
to attempt the preservation of the pulmonary valve in every single
patient during repair of tetralogy of Fallot. This technique
guarantees superior results in terms of pulmonary valve
competence at discharge compared with our standard repair. In
cases where the pulmonary valve cannot be preserved, these
patients can be easily converted to the standard approach without
additional risk.ery c February 2014
